HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tribl, G G Articles by Auff, E Search for Related Content PubMed PubMed Citation Articles by Tribl, G G Articles by Auff, E

Apomorphine in idiopathic restless legs syndrome: an exploratory study

Department of Neurology, University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Dr Gotthard G Tribl
Department of Neurology, University of Vienna, Vienna General Hospital, Waehringer Guertel 18–20, A-1097 Vienna, Austria; gotthard.tribl{at}meduniwien.ac.at

Background: Dopaminergic and opioidergic drugs have been found to be effective in patients with restless legs syndrome (RLS).

Objectives: To test the effect of apomorphine—a combined opioidergic and dopaminergic agonist—and subsequent selective antagonism by naloxone and metoclopramide on subjective and objective symptoms in patients with idiopathic RLS.

Methods: Nine patients with RLS were pretreated with oral domperidone for three days. A modified suggested immobilisation test (SIT) was carried out between 8 pm and 1 am under the following conditions of intravenous drug administration: baseline–apomorphine–apomorphine plus naloxone–apomorphine plus metoclopramide. Outcome variables were a visual analogue scale (VAS) of subjective RLS symptoms and EMG documented periodic leg movements while awake (PLMW).

Results: Compared with baseline, apomorphine resulted in a rapid and significant improvement in subjective RLS symptoms as measured by VAS (54.5% improvement; p = 0.011), and an almost immediate cessation of PLMW, measured by PLMW index (98.0% improvement; p = 0.012). Neither additional naloxone nor metoclopramide blocked this effect significantly. While given apomorphine with metoclopramide, there was a trend to reappearance of PLMW.

Conclusions: Apomorphine may be an effective treatment for idiopathic RLS. Its effectiveness may reflect both to its dopaminergic and its opioidergic activity, and is not diminished significantly by blocking only one of these pathways. The trend to a worsening of the PLMW index with metoclopramide hints at a primarily dopaminergic effect of apomorphine in idiopathic RLS.

Abbreviations: IRLSSG, International RLS Study Group; PET, positron emission tomography; PLMS, periodic limb movements during sleep; PLMW, periodic limb movements during wakefulness; RLS, restless legs syndrome; SIT, suggested immobilisation test; SPECT, single photon emission computed tomography; VAS, visual analogue scale

Keywords: restless legs syndrome; apomorphine; immobilisation test

This article has been cited by other articles:

				H. Marcovitch What's new this month in BMJ Journals BMJ, February 12, 2005; 330(7487): 330 - 330. [Full Text] [PDF]